These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9167504)

  • 1. Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials.
    Spiegel DA; Bruce TJ
    Am J Psychiatry; 1997 Jun; 154(6):773-81. PubMed ID: 9167504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiety sensitivity.
    Fava GA
    Am J Psychiatry; 1996 Aug; 153(8):1109-10. PubMed ID: 8678187
    [No Abstract]   [Full Text] [Related]  

  • 3. Benzodiazepine treatment of panic and agoraphobic symptoms: use, dependence, toxicity, abuse.
    Salzman C
    J Psychiatr Res; 1993; 27 Suppl 1():97-110. PubMed ID: 7908335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined psychotherapy plus benzodiazepines for panic disorder.
    Watanabe N; Churchill R; Furukawa TA
    Cochrane Database Syst Rev; 2009 Jan; (1):CD005335. PubMed ID: 19160253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does cognitive behavior therapy assist slow-taper alprazolam discontinuation in panic disorder?
    Spiegel DA; Bruce TJ; Gregg SF; Nuzzarello A
    Am J Psychiatry; 1994 Jun; 151(6):876-81. PubMed ID: 8184997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of panic disorder with agoraphobia: randomized placebo-controlled trial of four psychosocial treatments combined with imipramine or placebo.
    Marchand A; Coutu MF; Dupuis G; Fleet R; Borgeat F; Todorov C; Mainguy N
    Cogn Behav Ther; 2008; 37(3):146-59. PubMed ID: 18608313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.
    Otto MW; Pollack MH; Sachs GS; Reiter SR; Meltzer-Brody S; Rosenbaum JF
    Am J Psychiatry; 1993 Oct; 150(10):1485-90. PubMed ID: 8379551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up on the treatment of panic disorder with or without agoraphobia: a quantitative review.
    Bakker A; van Balkom AJ; Spinhoven P; Blaauw BM; van Dyck R
    J Nerv Ment Dis; 1998 Jul; 186(7):414-9. PubMed ID: 9680042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined pharmacotherapy and cognitive behavior therapy in the treatment of panic disorder.
    Gelder MG
    J Clin Psychopharmacol; 1998 Dec; 18(6 Suppl 2):2S-5S. PubMed ID: 9872706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "My new Alfa Romeo GT is not in the garage any more": Cognitive behavioural therapy of panic disorder with agoraphobia co morbid with psychosis.
    Gruber EN; Dordević V; Biocina-Martić S; Agius M
    Psychiatr Danub; 2006 Dec; 18(3-4):205-11. PubMed ID: 17099612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased probability of remaining in remission from panic disorder with agoraphobia after drug treatment in patients who received concurrent cognitive-behavioural therapy: a follow-up study.
    Biondi M; Picardi A
    Psychother Psychosom; 2003; 72(1):34-42. PubMed ID: 12466636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Panic disorder and agoraphobia: what is effective?].
    Bandelow B; Sievert K; Röthemeyer M; Hajak G; Broocks A; Rüther E
    Fortschr Neurol Psychiatr; 1995 Nov; 63(11):451-64. PubMed ID: 8575719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia.
    van Balkom AJ; de Beurs E; Koele P; Lange A; van Dyck R
    J Nerv Ment Dis; 1996 Feb; 184(2):133-5. PubMed ID: 8596113
    [No Abstract]   [Full Text] [Related]  

  • 14. Issues in the assessment of treatment response in panic disorder with special reference to fluvoxamine.
    Ninan PT
    J Clin Psychiatry; 1997; 58 Suppl 5():24-31. PubMed ID: 9184624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of alprazolam discontinuation with and without cognitive behavior therapy in panic disorder.
    Bruce TJ; Spiegel DA; Gregg SF; Nuzzarello A
    Am J Psychiatry; 1995 Aug; 152(8):1156-60. PubMed ID: 7625463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Integrated treatment strategies in panic disorder with agoraphobia and depressive disorder].
    Boerner RJ
    Nervenarzt; 1995 Mar; 66(3):212-6. PubMed ID: 7753246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia.
    Bakker A; van Balkom AJ; van Dyck R
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S25-30. PubMed ID: 11110016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review of the long-term effectiveness of cognitive behavioral therapy compared to medications in panic disorder.
    Nadiga DN; Hensley PL; Uhlenhuth EH
    Depress Anxiety; 2003; 17(2):58-64. PubMed ID: 12621593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What treatments do patients with panic disorder and agoraphobia get?
    Bandelow B; Sievert K; Röthemeyer M; Hajak G; Rüther E
    Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):165-71. PubMed ID: 7669824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment refractory panic disorder--success of a combined treatment with imipramine, moclobemide and behavior therapy].
    Boerner RJ
    Psychiatr Prax; 1995 Jan; 22(1):30-2. PubMed ID: 7892341
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.